Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial
Larissa I. van der Windt, Job Klumper, Ruben G. Duijnhoven, Marjolein Kok, Carrie Ris‐Stalpers, Marjon A. de Boer, Anton H. van Kaam, Eva Pajkrt, Ben W. Mol, Kate F. Walker, Fionnuala M. McAuliffe, Joris van der Post, Carolien Roos, Martijn A. Oudijk, Jelle Schaaf, Jim van Eyck, H.M. Knol, Marieke Sueters, Liesbeth Scheepers, David P. van der Ham, Judith O. E. H. van Laar, Eline S.A. van den Akker, Ralph R. Scholten, Nicolette van Gemund, Karlijn C. Vollebregt, Harrie Visser, Sanne J. Gordijn, Mireille N. Bekker, Josje Langenveld
Topics & Concepts
MedicinePlaceboRandomized controlled trialObstetricsThreatened speciesInternal medicineAlternative medicineBiologyEcologyPathologyHabitatPreterm Birth and ChorioamnionitisNeonatal Respiratory Health ResearchNeonatal and fetal brain pathology